Valuation : Legend Biotech Corporation

Market Cap 4.01B 3.44B 3.22B 2.95B 5.55B 383B 5.57B 38.13B 14.91B 193B 15.04B 14.72B 638B P/E 2026 *
2,541x
P/E 2027 * 23.4x
Enterprise Value 3.07B 2.64B 2.47B 2.26B 4.26B 293B 4.27B 29.22B 11.42B 148B 11.53B 11.28B 489B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.62x
Free-Float
98.75%
Yield 2026 *
-
Yield 2027 * -
1 day-0.36%
1 week-3.36%
Current month+10.76%
1 month+6.62%
3 months-27.91%
6 months+8.13%
Current year-5.50%
1 week 20.32
Extreme 20.32
22.37
1 month 18.33
Extreme 18.33
23.24
Current year 16.24
Extreme 16.24
37.5
1 year 16.24
Extreme 16.24
37.5
3 years 16.24
Extreme 16.24
72.38
5 years 16.24
Extreme 16.24
77.32
10 years 16.24
Extreme 16.24
77.32
Manager TitleAgeSince
Chief Executive Officer 54 2026-07-23
Director of Finance/CFO - 2025-08-17
Chief Operating Officer - -
Director TitleAgeSince
Chairman 57 2020-11-05
Director/Board Member 69 2020-04-30
Director/Board Member 64 2020-04-30
Date Insider Type Main position Quantity % Market Cap.
8/14/26 Free

Chief Executive Officer

4,908 0.0017%
7/24/26 Other

Chief Executive Officer

30,234 0.0105%
6/30/26 Don

Chief Executive Officer

-3,382 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-3.36%-40.83%-70.26% 4.01B
+3.31%-3.70%+61.03%+103.64% 70.42B
+1.09%+2.51%+49.34%+93.23% 65.4B
-0.44%+0.87%+8.59%-7.31% 28.28B
-0.49%+5.43%+54.81%+13.87% 26.57B
-1.74%-2.12%-8.99%+466.29% 27.16B
+0.37%+1.21%+36.55%-17.60% 20.09B
+1.02%+6.43%+269.42%+420.34% 20.61B
+0.77%+0.19%+8.01%+520.34% 15.87B
-1.66%+2.64%+43.09%+148.44% 13.9B
Average +0.21%+0.19%+48.10%+167.10% 29.23B
Weighted average by Cap. +0.86%+0.59%+54.15%+152.49%

Financials

2026 *2027 *
Net sales 1.43B 1.23B 1.15B 1.06B 1.99B 137B 1.99B 13.65B 5.33B 69.03B 5.38B 5.27B 228B 1.81B 1.55B 1.45B 1.33B 2.51B 173B 2.52B 17.23B 6.73B 87.15B 6.8B 6.65B 288B
Net income -12.85M -11.03M -10.33M -9.46M -17.81M -1.23B -17.86M -122M -47.8M -618M -48.24M -47.2M -2.05B 228M 195M 183M 167M 315M 21.73B 316M 2.17B 847M 10.95B 854M 836M 36.25B
Net Debt -936M -804M -753M -689M -1.3B -89.43B -1.3B -8.91B -3.48B -45.07B -3.52B -3.44B -149B -1.08B -927M -867M -794M -1.5B -103B -1.5B -10.27B -4.02B -51.96B -4.05B -3.97B -172B
Logo Legend Biotech Corporation
Legend Biotech Corporation is a global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing and commercialization of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Employees
3,200
Date Price Change Volume
26-08-27 US$20.54 -0.68% 484,214
26-08-26 US$20.68 -2.91% 925,072
26-08-25 US$21.30 +1.72% 1,408,246
26-08-24 US$20.94 -4.03% 1,930,489
26-08-21 US$21.82 +2.63% 1,424,313
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
20.68USD
Average target price
49.25USD
Spread / Average Target
+138.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LEGN Stock